Too many patients with a rare disease remain undiagnosed. Prof. Dr. David Cassiman, head of the metabolic center in UZ Leuven, shares his experience on the Rare Disease landscape in Belgium, with special attention for Fabry disease.

Only 40% of Fabry patients are currently diagnosed in our country. Therefore, systematic screening in high-risk populations is advised for Cardiologists, Neurologists, and Nephrologists. Prof. Dr. Cassiman explains why it is so important.

He also touches upon how Artificial Intelligence (AI) can add value in this domain. What can we expect now and in the future? Curious about the opinion of a Belgian expert? Listen to (t)his podcast! 

C-ANPROM/BE/FAB/0051 – November 2023
C-ANPROM/BE/FAB/0044